Cowen analyst Gary Taylor lowered the firm’s price target on Humana to $581 from $647 and keeps an Outperform rating on the shares. The analyst updated his model for 4Q22 results the business resegmentation and the 2024 Advance Notice.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HUM:
- Humana price target lowered to $575 from $635 at Credit Suisse
- Humana price target lowered to $590 from $625 at Stephens
- Humana price target lowered to $620 from $645 at UBS
- Humana appoints Sanjay Shetty to lead health care services business
- Humana sees FY23 adjusted EPS ‘at least’ $28.00, consensus $28.00
